Issue Date: October 12, 2009
Carbogen, Nextpharma Link Drug Services
Carbogen Amcis and NextPharma Technologies are forming an alliance to combine Carbogen’s highly potent active pharmaceutical ingredient (API) manufacturing capabilities in Switzerland with NextPharma’s dosage-form drug-manufacturing services, which it offers from seven sites across North America and Europe. API manufacturer Lonza seeks to create a similar combined service through its planned acquisition of Patheon (C&EN, Aug. 31, page 10).
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society